Top Back to top

Current Treatment of HCV infection after HSCT

Study number:
Type of transplant:
Short title:
HCV study
Study status:
Deadline for data collection:
Study design:
Over the period of 24 months, all HCV-RNA positive patients who received
Primary objective:
Report the treatment approach in patients HCV-RNA+
Key inclusion criteria:
All HCV-RNA positive patients transplanted from anytime until May 2017, followed
Principal investigator:
Malgorzata Mikulska
Principal investigator email:
Study coordinator email:

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to